Search Results - Agneta Siegbahn
- Showing 1 - 20 results of 83
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Biomarkers in atrial fibrillation: a clinical review by Ziad Hijazi, Jonas Oldgren, Agneta Siegbahn, C. B. Granger, Lars Wallentin
Published 2013Revisão -
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis. by Klaus Hansen, Matilda Johnell, Agneta Siegbahn, Charlotte Rorsman, Ulla Engström, Christer Wernstedt, Carl‐Henrik Heldin, Lars Rönnstrand
Published 1996Artigo -
18
-
19
-
20
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease by Tomas Jernberg, Bertil Lindahl, Agneta Siegbahn, Bertil Andrén, Gunnar Frostfeldt, Bo Lagerqvist, Mats Stridsberg, Per Venge, Lars Wallentin
Published 2003Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cardiology
Biology
Myocardial infarction
Biochemistry
Atrial fibrillation
Confidence interval
Engineering
Chemistry
Disease
Mechanical engineering
Stroke (engine)
Hazard ratio
Biomarker
Genetics
Heart failure
Immunology
Troponin
Gene
Coronary artery disease
Acute coronary syndrome
Natriuretic peptide
Proportional hazards model
Warfarin
Bioinformatics
Endocrinology
Inflammation
Aspirin
Genotype